
|Articles|May 1, 2004
Managed care hassles easing up
Trying to get out from under coverage denials, late payments, and mountains of paperwork
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Envudeucitinib Achieves 54% PASI 100 Rate at 48 Weeks in Phase 3 Extension
2
Phase 3 STOP-HS Trials Highlight Promise of Oral JAK1 Inhibition for Moderate to Severe Disease
3
Biologic Therapies in AD and CSU: Progress and the Push for Precision Medicine
4
Case Report Highlights Rural Care Gaps in Recurrent Merkel Cell Carcinoma
5











